Meta Information
ID:alcar
Name:Acetyl-L-Carnitine
Schema Version:1.5
Alternate Names
- ALCAR
- ALC
Active Compound
acetyl-l-carnitine
Intervention Type
therapeutic_agent
Delivery
Route:
oral
Scope:
- systemic
Regulatory Status
- us:dietary_supplement
- eu:rx_drug
Indication
Focus:
- healthspan
- symptom_management
Description:
Explored for improving mitochondrial energy production, cognitive function, and nerve health in aging individuals.
Typical Protocol
- Typical healthspan-focused doses range from 500 mg to 2,000 mg daily, often split into two doses.
Expected Cost Mean
Low Cost:
15
High Cost:
40
Cost Type:
monthly
Description:
Widely available as an over-the-counter supplement; not covered by insurance for healthspan.
Summary
Acetyl-L-Carnitine (ALCAR) is an amino acid derivative crucial for transporting fatty acids into mitochondria to be burned for energy. It also donates its acetyl group, which can support the synthesis of acetylcholine, a key neurotransmitter for memory and cognition. Due to its dual role in energy metabolism and brain function, it is investigated for mitigating age-related declines in these areas.
Purpose
Supports mitochondrial energy production and brain neurotransmitter synthesis.
Card Summary
A mitochondrial nutrient that aids energy metabolism and may support cognitive function.
Drug Class
null
Drugs In Class
Empty Array
Impact
Score:
4.5
Justification:
Benefits are targeted towards mitochondrial support and cognition, not broad aging pathways.
Evidence
Grade:
B
Score:
5.5
Justification:
Human trials exist but often show modest or mixed results for healthspan outcomes.
Safety
Score:
3
Justification:
Generally well-tolerated with mild gastrointestinal side effects at typical doses.
Flags
- May cause nausea, vomiting, or a 'fishy' body odor at high doses.
- Use with caution in individuals with hypothyroidism as it may interfere with thyroid hormone action.
- May increase the effects of anticoagulant drugs like warfarin.
- Theoretically contributes to TMAO production, a controversial cardiovascular risk marker.
Verdict
A targeted supplement for mitochondrial and cognitive support with a good safety profile.
Created
2026-05-05T21:56:18.225746Z
Ai Model
Gemini 2.5 Pro (High)